Psykey, Inc. (OTCMKTS:CEOS) Sees Significant Decline in Short Interest

Psykey, Inc. (OTCMKTS:CEOS) was the target of a large decrease in short interest in January. As of January 31st, there was short interest totalling 2,400 shares, a decrease of 89.1% from the January 15th total of 22,000 shares. Based on an average daily trading volume, of 984,800 shares, the short-interest ratio is currently 0.0 days.

Psykey Stock Performance

Shares of CEOS stock traded up $0.00 during trading hours on Wednesday, reaching $0.01. 444,512 shares of the company’s stock were exchanged, compared to its average volume of 1,264,450. The company’s 50 day moving average is $0.02 and its two-hundred day moving average is $0.02. Psykey has a 1 year low of $0.01 and a 1 year high of $0.04.

Psykey Company Profile

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.